SCHEMBL7207745

SCHEMBL7207745

CC(C)(C)[Si](C)(C)O[CH]c1ccccc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 1/20 0.33
TRPA1 O75762 1/20 0.32
MAPK1 P28482 1/20 0.32
CYP2C19 P33261 1/20 0.32
IDO1 P14902 2/20 0.31
NFE2L2 Q16236 1/20 0.31
ALDH1A1 P00352 4/20 0.31
TSHR P16473 1/20 0.31
MAOB P27338 1/20 0.31
CYP2A6 P11509 1/20 0.31
HSP90AA1 P07900 1/20 0.31
HSP90AB1 P08238 1/20 0.31
MEN1 O00255 2/20 0.31
KMT2A Q03164 2/20 0.31
EGFR P00533 1/20 0.31
KDM4E B2RXH2 1/20 0.31
USP2 O75604 1/20 0.31
TP53 P04637 1/20 0.31
CYP3A4 P08684 1/20 0.31
MAPT P10636 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1899986 0.80 TRPA1 (0.38) TRPA1CYP2C19IDO1NFE2L2ALDH1A1
SCHEMBL2844260 0.78 TRPA1 (0.37) TRPA1CYP2C19NFE2L2ALDH1A1TSHR
SCHEMBL28886988 0.72 ESR1 (0.31) MAPK1
SCHEMBL28495781 0.71 BACE1 (0.36) IDO1ALDH1A1CYP2A6MEN1KMT2A
SCHEMBL9699570 0.69 TRPA1 (0.53) TRPA1MAPK1CYP2C19ALDH1A1HSP90AA1
SCHEMBL6111605 0.69 TDP1 (0.38) TDP1TRPA1MAPK1CYP2C19NFE2L2
SCHEMBL7395928 0.68 IDO1 (0.55) IDO1MAOBMEN1KMT2AHSD17B10
SCHEMBL7395933 0.68 IDO1 (0.55) IDO1MAOBMEN1KMT2AHSD17B10
SCHEMBL29566039 0.68 IDO1 (0.55) IDO1MAOBMEN1KMT2AHSD17B10
SCHEMBL2368966 0.67 PREP (0.45) MAPK1ALDH1A1TSHRHSP90AA1HSP90AB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1992004327-A1 ANTIVIRAL COMPOUNDS AND ANTIHYPERTENSIVE COMPOUNDS SCHERING CORPORATION (US) 1992-03-19 WO claimed
EP-1044204-B1 PROCESS FOR THE PREPARATION OF ALPHA-OXOLACTAMS RES CORP TECHNOLOGIES INC (US) 2003-06-04 EP disclosed
US-6255479-B1 REACTING AN ALPHA-DIAZOLACTAM WITH AN EPOXIDE, IN THE PRESENCE OF A TRANSITION METAL CATALYST (OF RHODIUM, COPPER, OR RHENIUM), YIELDS ALPHA-OXOLACTAM RESEARCH CORPORATION TECHNOLOGIES, INC. 2001-07-03 US disclosed
EP-1044204-A1 PROCESS FOR THE PREPARATION OF ALPHA-OXOLACTAMS Research Corporation Technologies, Inc (US) 2000-10-18 EP disclosed
US-5942522-A 1-BENZYL-3-ETHOXYCARBONYL-4-DIMETHYLAMINOETHOXY-6-METHYL-2-(1H) -QUINOLINONE; ANTIVIRAL AGAINST DNA CONTAINING VIRUSES, SUCH AS HERPES GROUP VIRUSES SCHERING CORPORATION (US) 1999-08-24 US disclosed
WO-1999033837-A1 PROCESS FOR THE PREPARATION OF α-OXOLACTAMS RESEARCH CORPORATION TECHNOLOGIES, INC. (US) 1999-07-08 WO disclosed